These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11899064)

  • 1. Metabonomic applications in toxicity screening and disease diagnosis.
    Shockcor JP; Holmes E
    Curr Top Med Chem; 2002 Jan; 2(1):35-51. PubMed ID: 11899064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated toxicity screening using NMR and pattern recognition-based methods.
    Holmes E; Shockcor JP
    Curr Opin Drug Discov Devel; 2000 Jan; 3(1):72-8. PubMed ID: 19649840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra.
    Holmes E; Antti H
    Analyst; 2002 Dec; 127(12):1549-57. PubMed ID: 12537357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology.
    Coen M; Holmes E; Lindon JC; Nicholson JK
    Chem Res Toxicol; 2008 Jan; 21(1):9-27. PubMed ID: 18171018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks.
    Holmes E; Nicholson JK; Tranter G
    Chem Res Toxicol; 2001 Feb; 14(2):182-91. PubMed ID: 11258967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project.
    Lindon JC; Nicholson JK; Holmes E; Antti H; Bollard ME; Keun H; Beckonert O; Ebbels TM; Reily MD; Robertson D; Stevens GJ; Luke P; Breau AP; Cantor GH; Bible RH; Niederhauser U; Senn H; Schlotterbeck G; Sidelmann UG; Laursen SM; Tymiak A; Car BD; Lehman-McKeeman L; Colet JM; Loukaci A; Thomas C
    Toxicol Appl Pharmacol; 2003 Mar; 187(3):137-46. PubMed ID: 12662897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements.
    Lindon JC; Keun HC; Ebbels TM; Pearce JM; Holmes E; Nicholson JK
    Pharmacogenomics; 2005 Oct; 6(7):691-9. PubMed ID: 16207146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A metabonomic approach for mechanistic exploration of pre-clinical toxicology.
    Coen M
    Toxicology; 2010 Dec; 278(3):326-40. PubMed ID: 20699110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical total correlation spectroscopy editing of 1H NMR spectra of biofluids: application to drug metabolite profile identification and enhanced information recovery.
    Sands CJ; Coen M; Maher AD; Ebbels TM; Holmes E; Lindon JC; Nicholson JK
    Anal Chem; 2009 Aug; 81(15):6458-66. PubMed ID: 19580292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging research of human lung cancer tissues by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy (HRMAS
    Chen W; Lu S; Wang G; Chen F; Bai C
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e232-e238. PubMed ID: 27670847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical reproducibility in (1)H NMR-based metabonomic urinalysis.
    Keun HC; Ebbels TM; Antti H; Bollard ME; Beckonert O; Schlotterbeck G; Senn H; Niederhauser U; Holmes E; Lindon JC; Nicholson JK
    Chem Res Toxicol; 2002 Nov; 15(11):1380-6. PubMed ID: 12437328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of NMR-based metabonomics in neurological disorders.
    Holmes E; Tsang TM; Tabrizi SJ
    NeuroRx; 2006 Jul; 3(3):358-72. PubMed ID: 16815219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts.
    Beckonert O; Keun HC; Ebbels TM; Bundy J; Holmes E; Lindon JC; Nicholson JK
    Nat Protoc; 2007; 2(11):2692-703. PubMed ID: 18007604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach.
    Ebbels TM; Keun HC; Beckonert OP; Bollard ME; Lindon JC; Holmes E; Nicholson JK
    J Proteome Res; 2007 Nov; 6(11):4407-22. PubMed ID: 17915905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty years of metabonomics: so what has metabonomics done for toxicology?
    Griffin JL
    Xenobiotica; 2020 Jan; 50(1):110-114. PubMed ID: 31826699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo toxicity screening programs using metabonomics.
    Robosky LC; Robertson DG; Baker JD; Rane S; Reily MD
    Comb Chem High Throughput Screen; 2002 Dec; 5(8):651-62. PubMed ID: 12470262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabonomics: its potential as a tool in toxicology for safety assessment and data integration.
    Griffin JL; Bollard ME
    Curr Drug Metab; 2004 Oct; 5(5):389-98. PubMed ID: 15544433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies.
    Aardema MJ; MacGregor JT
    Mutat Res; 2002 Jan; 499(1):13-25. PubMed ID: 11804602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic profiling as a tool for understanding mechanisms of toxicity.
    Clarke CJ; Haselden JN
    Toxicol Pathol; 2008 Jan; 36(1):140-7. PubMed ID: 18337232
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.